Shaoxing Second Hospital Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial
2012
NCT03880968
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Shaoxing Second Hospital